Evidence map›Paper›PMID 42339132›Full record

ArticleInternational medical case reports journal2026

Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature.

Yu Wang, Mengsi Zhang, Guangzong Su, Qiao Zhou

Abstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu WangDepartment of Pathology, Wuhan Asia General Hospital, Wuhan, 430000, People's Republic of China.ORCID 0009-0004-0341-9533
Mengsi ZhangDepartment of Pathology, Wuhan Asia General Hospital, Wuhan, 430000, People's Republic of China.ORCID 0000-0002-4841-6932
Guangzong SuDepartment of Radiology, Wuhan Asia General Hospital, Wuhan, 430000, People's Republic of China.ORCID 0009-0009-2269-9071
Qiao ZhouDepartment of Pathology, Wuhan Asia General Hospital, Wuhan, 430000, People's Republic of China.ORCID 0009-0000-9287-7886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Papillary renal neoplasm with reversed polarity is a rare entity, with its latest definition established only in 2019. Given its rarity, with less than 100 reported cases, further characterization is needed to enhance diagnostic accuracy and inform management strategies. Case Presentation: We report a case in a 64-year-old Chinese male with an incidentally discovered a size of 5.2cm×4.0cm left renal mass on imaging. The patient has a medical history of coronary heart disease and left lower limb numbness. Further evaluation via contrast-enhanced CT confirmed that a nodular slightly hyperdense lesion approximately 52mm*39mm in size is noted in the left kidney. He underwent a partial nephrectomy and postoperative pathology confirmed PRNRP. Under the microscope, papillary structures can be seen lining a single layer of cuboidal epithelial cells in the left renal cyst and tumor. The nucleus appears low-grade, round, reverse nuclear polarity, and the nucleolus is not obvious. The tumor has not invaded the renal parenchyma. Immunohistochemistry confirmed P504S (+), CK7 (+), CK-H (+), GATA-3 (+), E-Cadherin (+), CK20 (Partial weak+), Vimentin (-), CD10 (individual+), CA-IX (-), RCC (-), Ki-67 (Li 1%). Postoperative recovery was excellent. The patient in this case did not receive any other treatment after surgery. Through regular telephone follow-up for 3 months, the patient's condition was good. Ultrasound examination was performed during the period, and no recurrence or metastasis was found. Conclusion: This article presents a case of papillary renal neoplasm with reversed polarity in an elderly male patient. By reviewing the patient's diagnosis and treatment process and revisiting relevant literature, the clinicopathological features of this tumor are elucidated to enhance understanding of this rare renal tumor. This case reinforces the distinct morphological and molecular profile of PRNRP, distinguishing it from other papillary RCC subtypes. The indolent behavior, absence of metastatic cases, and characteristic molecular profiling and immunohistochemical markers highlight the importance of accurate classification for optimal patient management. As PRNRP is recently classified, continued study is essential to refine diagnostic, therapeutic, and surveillance strategies for this rare renal neoplasm.

Indexed as

immunohistochemistrypapillary renal neoplasm with reverse polarityPRNRPrare caserenal tumors

Identifiers

PMID42339132
PMCPMC13284039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.